Dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders
CEGIR Mission Statement
The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations.
Join One of Our Research Studies
Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases
Find a Study
Podcast: Eosinophilic Gastrointestinal Disorders: A New Path
Listen to this episode of the Pediatric and Developmental Pathology podcast.
CEGIR’s Marc Rothenberg Receives AAAAI 2023 Distinguished Scientist Award
Marc Rothenberg, MD, PhD, has received the American Academy of Allergy, Asthma & Immunology (AAAAI) 2023 Distinguished Scientist Award. Rothenberg will be recognized during the 2023 AAAAI Annual Meeting on February 24-26.
The New England Journal of Medicine Editors Speak on Striving for Diversity in Research Studies
The New England Journal of Medicine editors explore racial and ethnic gaps in large research studies, along with the cause and effect of such disparities.
Get to Know Us
CEGIR Updates
An update from the Consortium of Eosinophilic Gastrointestinal Disease Researchers
Learn More